Amgen, Inc.

-$2.40 (-1.0%)
Closing price January 20, 2022
Wednesday afternoon's top analyst upgrades and downgrades included Adobe, Altria, Amgen, Beyond Meat, BP, Murphy Oil, Northrop Grumman, Occidental Petroleum, Peloton Interactive, Pfizer,...
Here's the final list of 2022's Dogs of the Dow.
Here is a look at the stocks currently in the running to be Dogs of the Dow for 2022.
Thursday afternoon's top analyst upgrades and downgrades included AbbVie, Allstate, Amgen, Occidental Petroleum, Pfizer, SunPower, Twilio and Yum! Brands.
Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of the best entry points in months. The stocks also are rated Buy at top...
Monday’s top analyst upgrades and downgrades included Amgen, Apple, AT&T, Chevron, Dollar General, Fastly, Ford, Hertz, Kroger, Marvell Technology, Peloton Interactive,, Stitch Fix...
Friday afternoon's analyst upgrades and downgrades included Alibaba, AIG, Amgen, Applied Materials, Bath & Body Works, Delta Air Lines, Kohl’s, Macy’s, Snowflake, Tapestry and Walmart.
Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets, attractive dividend yields and improved cost structures. With even moderate...
These five outstanding blue chip stocks have been hit hard this year and are offering growth and income investors incredible entry points and some big and, most importantly, reliable dividends. They...
While not suited for conservative income investors, these two top biotech stocks could have huge total return potential and offer investors with a touch more risk tolerance some very tempting entry...
Thursday's top analyst upgrades and downgrades included Amgen, Biogen, Commscope, Lockheed Martin, Northrop Grumman, ONEOK, Plug Power and Roku.
Tuesday’s top analyst upgrades and downgrades included Amgen, Cirrus Logic, Hain Celestial, Johnson & Johnson, Lam Research, Merck, Spotify Technology and Vertex Pharmaceuticals.
24/7 Wall St. takes a look at Georgia Representative Marjorie Taylor Greene and what stock trades are going on around her.
With the first quarter soon coming to an end, now is the time to move from momentum to strong growth stocks. Goldman Sachs feels these four could offer extra strength in a pricey stock market.
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.